1. Home
  2. RLI vs INDV Comparison

RLI vs INDV Comparison

Compare RLI & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RLI Corp. (DE)

RLI

RLI Corp. (DE)

HOLD

Current Price

$50.44

Market Cap

4.5B

Sector

Finance

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$37.70

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLI
INDV
Founded
1965
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.4B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
RLI
INDV
Price
$50.44
$37.70
Analyst Decision
Hold
Analyst Count
7
0
Target Price
$62.40
N/A
AVG Volume (30 Days)
933.8K
1.7M
Earning Date
04-22-2026
06-08-2026
Dividend Yield
5.16%
N/A
EPS Growth
16.84
8100.00
EPS
0.60
0.69
Revenue
$1,882,448,000.00
$1,239,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.53
N/A
P/E Ratio
$83.47
$51.35
Revenue Growth
6.33
4.29
52 Week Low
$47.26
$13.42
52 Week High
$76.41
$41.00

Technical Indicators

Market Signals
Indicator
RLI
INDV
Relative Strength Index (RSI) 42.85 56.80
Support Level $47.26 $35.36
Resistance Level $54.18 $38.08
Average True Range (ATR) 1.41 1.40
MACD 0.11 -0.35
Stochastic Oscillator 28.73 85.90

Price Performance

Historical Comparison
RLI
INDV

About RLI RLI Corp. (DE)

RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety, and it derives a majority of its revenue from the Casualty segment.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: